STOCKHOLM, Sept. 24, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) ...
Erin Kelly is likely going to forget her eight-year-old daughter Evie’s name before her little girl finishes high school. At just 29-years-old, the Australian mom has been diagnosed with a rare ...
Australian musician Emma Sheppard has spoken of her decision to undergo IVF so she could genetically test her embryos for ...
While lifesaving vaccines face a relentless onslaught from the Trump administration—with fervent anti-vaccine advocate Robert ...
The actor, who inherited a high-risk gene for Alzheimer’s disease, explores ways to potentially slow down the disease.
Hosted on MSN
Alzheimer's drug Lecanemab approved by Therapeutic Goods Administration for use in Australia
A promising new Alzheimer's drug has been green-lit by the national medicines regulator, after two previous failed attempts to register it for use in Australia. Lecanemab, sold under the brand name ...
XPro™ is a next-generation, selective soluble TNF inhibitor designed to selectively neutralize soluble TNF (sTNF) and restore ...
Dementia Australia is excited to announce respected ABC Canberra journalist and broadcaster Adrienne Francis as its newest Ambassador.Adrienne's ...
TOKYO and CAMBRIDGE, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (BIIB) (Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results